Predictive value of breast cancer cognitions and attitudes toward genetic testing on women’s interest in genetic testing for breast cancer risk by Reitz, Frauke et al.
Predictivevalueofbreastcancercognitionsandattitudes
toward genetic testing on women’s interest in genetic
testing for breast cancer risk
Der Einfluss von brustkrebsspezifischen Kognitionen und von
Einstellungen gegenüber genetischen Testungen auf das Interesse von
Frauen an prädiktiver genetischer Brustkrebsdiagnostik
Abstract
In the past years advances in genetic technologies have led to an in-
creased interest in predictive genetic testing for breast cancer risk.
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Structural equation modeling was used to determine the predictive
valueofattitudinalandcognitivevariablesoninterestingenetictesting
for breast cancer risk. The resulting model achieved good fit indices,
and42%ofvariancecouldbeexplained.Womenwithmoreexpectations
concerning the test, more positive attitudes concerning genetic testing
in general, an increased breast cancer risk perception, and increased
breast cancer worries showed more interest in testing.
These findings suggest the need for information and counseling
strategies for low risk women which should focus in particular on de-
creasing unrealistic expectations concerning genetic testing for breast
cancer risk but also on decreasing perceived breast cancer risk and
breast cancer worries.
Zusammenfassung
DiegentechnologischenundgendiagnostischenFortschrittederletzten
JahrehabenzueinemvermehrtenInteresseanprädiktivergenetischer
Brustkrebsdiagnostik geführt. Obwohl Frauen mit einem geringen
Brustkrebsrisiko von einer solchen Testung nicht profitieren können,
zeigen Studien ein zunehmendes Interesse von Frauen der Allgemein-
bevölkerung an genetischer Brustkrebsdiagnostik.
Ziel der Studie war es, Faktoren zu identifizieren, mit deren Hilfe das
Interesse von Frauen mit einem geringen Brustkrebsrisiko an geneti-
scherBrustkrebsdiagnostikvorhergesagtwerdenkann.Hierfürwurden
377 Frauen der Allgemeinbevölkerung, die weder eine erkrankte Erst-
gradangehörige hatten, noch selbst an Brustkrebs erkrankt waren, te-
lefonisch und schriftlich befragt. Mithilfe eines Strukturgleichungsmo-
dells wurde der Einfluss brustkrebsspezifischer Kognitionen sowie ein-
stellungsbezogener Variablen auf das Interesse an genetischer Brust-
krebsdiagnostik überprüft. Das resultierende Modell erreichte gute Fit-
Indices und konnte 42% der Varianz des Interesses an genetischer
Brustkrebsdiagnostikerklären.FrauenmithöherenErwartungenandie
Testung, einer positiven Einstellung gegenüber genetischen Testungen
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Research Article OPEN ACCESSim allgemeinen, einer höheren Einschätzung des persönliches Brust-
krebsrisikossowiemitvermehrtenbrustkrebsspezifischenÄngstenund
Sorgen zeigten ein größeres Interesse an genetischer Brustkrebsdia-
gnostik.
Die Ergebnisse der Studie verdeutlichen, dass auch Frauen mit einem
geringenBrustkrebsrisikoInteresseangenetischerBrustkrebsdiagnostik
haben. Für die Beratung sollten Informations- und Kommuniktionsstra-
tegien entwickelt werden, die insbesondere auf unrealistische Erwar-
tungen bezüglich genetischer Brustkrebsdiagnostik fokussieren und
diedarüberhinausdazubeitragen,daswahrgenommeneBrustkrebsri-
siko sowie erhöhte Ängste und Sorgen zu reduzieren.
Introduction
Advances in genetic technologies lead to more and more
changes in medical practice. The increasing knowledge
about genetic susceptibilities makes genetic testing for
inherited diseases like Huntington disease, hereditary
breast, ovarian or colon cancer, heart diseases, or
Alzheimer's diseases possible. Studies from different
countries have shown that genetic testing is becoming
generally accepted in the general public [1], [2], [3], [4],
[5], [6] and that some of the presently available gene
tests like predictive genetic testing for breast cancer risk
will be more and more commercialized [7], [8]. However,
thesenewdevelopmentsrequiredeliberatingaboutrisks
andbenefitsrelatedtogenetictesting.Weneedtoclarify
for whom genetic testing should be accessible [7], [9].
There is consensus that in regard to breast cancer, pre-
dictive genetic testing is only reasonable for high-risk
women with a family history of breast cancer. The test
offershigh-riskwomensomepotentialbenefitslikereceiv-
ing certainty about one's personal breast cancer risk or
getting recommendations about screening behavior and
medical treatment. However, genetic testing for breast
cancerriskisnotmeaningfulforlow-riskwomenbecause
most of them will obtain a negative test result which
cannotbeinterpretedwithouttestinganaffectedrelative
first [10]. Therefore, genetic testing will not give low-risk
women certainty about their breast cancer risk [11].
Although low-risk women will not benefit from the test,
there is an increasing interest in genetic testing among
women of the general public. Studies in the US reported
high ratesofinterestamongwomenatlow riskforbreast
cancer[12], [13], [14]. A high interestin this issue within
the general public or even to pursue genetic testing for
breast cancer risk was also found in Germany [15], [16].
Even though there is an only moderate association
between the intention to obtain genetic testing and the
actual uptake of the gene test [17], [18], we should un-
derstand the motives of low-risk women to be interested
in genetic testing for breast cancer risk in order to be
able to provide adequate information and thereby to re-
duce unrealistic expectations and hopes.
Breastcancerriskperceptionappearstobeofhighrelev-
ancefortheintentiontopursuegenetictestingforbreast
cancer risk. According to health behavior theories (e.g.
Health Belief Model [19]; Protection Motivation Theory
[20], [21]) risk perception - defined as a function of per-
ceived vulnerability and perceived severity - is a key vari-
able for predicting the intention to initiate and maintain
healthbehavior.Studiesontheintentiontoobtaingenetic
testingforbreastcancerriskmostlyfocusedonperceived
vulnerability for breast cancer. The findings suggest that
women's perceived vulnerability for breast cancer is
positivelyrelatedtotheintentiontoparticipateingenetic
testing for breast cancer risk [22], [23], [24], [25], [26],
and that perceived vulnerability for breast cancer is of
higher predictive value than actual breast cancer risk
[27], [28].
Other variables like cancer worries and knowledge also
influence the intention to participate in genetic testing
forbreastcancerrisk.Exaggeratedbreastcancerworries
increase the intention to obtain the gene test [26], [29],
[30] and can further influence perceived vulnerability for
breastcancer[31],[32],[33].Thus,breastcancerworries
may have a direct as well as an indirect impact on wo-
men's intentions to pursue testing. Furthermore, know-
ledge about breast cancer genetics was found to be of
predictivevalue.Womenwithlittleknowledgeweremore
interested in obtaining the test [34].
Specificexpectationsandfearsconcerninggenetictesting
for breast cancer risk - which could be seen as expres-
sions of women's attitudeconcerningthe test - were also
investigated as potential predictors of the intention to
participate in genetic testing. Studies have shown that
an increased hope for certainty about ones personal
breast cancer risk motivates women to pursue genetic
testing[35].Moreover,thehopetogetrecommendations
about screening behavior and medical treatment as well
as the hope to get information about the risk of ones
children increase the intention to obtain the test [36],
[37], [38], [39]. However, there is not much research
about whether fears concerning the gene test are also of
relevanceforwomen'sintentionstoparticipateingenetic
testing or not.
General attitudes toward genetic testing have not been
takenintoaccountyet.Therearesignificantassociations
betweenattitudesandtheintentiontoactingeneral[40],
[41], [42]. Some health behavior theories (e.g. Theory of
reasoned action [43], [44]) suggest that a positive atti-
tude toward a behavior increases the intention to initiate
this behavior. Thus, it can be assumed that women's
generalattitudeconcerninggenetictestingmaypositively
influence their intentions to pursue genetic testing for
breast cancer risk. Therefore, we need to investigate
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testingingeneralarealsoofpredictivevalueforwomen's
intentionstoobtaingenetictestingforbreastcancerrisk.
Most studies concerning factors that influence women's
intentions to participate in genetic testing for breast
cancer risk focused on women with a family history of
breastcancer. Thus, there is not much evidencewhether
thereportedfactorsalsopredicttheintentionsoflow-risk
women. Furthermore, the impact of attitudinal variables
- women's general attitudes concerning genetic testing
in particular - have not been included yet. In addition,
mostofthesestudiesreportedcorrelativefindingswithout
taking relationships between relevant variables into ac-
count. Therefore, the aim of the present study was to
identify factors that predict interest in genetic testing for
breastcancerriskoflow-riskwomeninthegeneralpublic
in Germany. As the intentionto pursue genetic testing for
breastcancerrisk seemsnot to be reasonableas a main
outcomevariableforwomenatlowriskforbreastcancer,
women's interest in testing as a more global construct
was focused. Structural equation modeling was used to
investigate the predictive value of breast cancer cogni-
tions on the one hand and attitudes concerning genetic
testing on the other hand. Perceived vulnerability, per-
ceived severity, breast cancer worries and knowledge
about breast cancer genetics were integrated in the
model as cognitive variables. Specific expectations and
fears concerninggenetictestingforbreastcancerriskas
well as attitudes toward genetic testing in general were
included as attitudinal variables.
Methods
Procedure
The present study was part of a larger study that investi-
gated attitudes and risk perception of German women
concerning breast cancer and predictive genetic testing
for breast cancer risk [15]. Participants were recruited
through a random sample of the registration office of
Freiburg/Germany,whichprovided4500postaladdresses
ofwomenaged18to65.Aletterinitiallyinformedwomen
with a telephone (n=2561) about study objectives and
offered a number to call to reject participation. As a next
step, women who did not reject participation were inter-
viewed in a brief telephone survey to check for eligibility
criteria (age, adequate language skills) as well as to as-
sess sociodemographic variables (age, marital status,
education, and employment status) (n=657). According
totheirbreastcancerriskstatusparticipantsweredivided
into three groups: 1. women with neither breast cancer
nor first-degree relatives with breast cancer, 2. women
with at least one first-degree relative with breast cancer,
3.womenwithbreastcancerthemselves.Finally,eligible
participantswhoagreedtotakepartinthestudy(n=652)
receivedaquestionnaireaboutattitudesandriskpercep-
tion concerning breast cancer and predictive genetic
testing as well as a consent form with a return envelope.
We received 68% (n=469) of the questionnaires sent.
Thus, about 18% of the initially informed women took
part in the study. The study was reviewed and approved
by the Ethics Committee of the Deutsche Gesellschaft
für Psychologie (DGPs).
Participants
Participants were 469 women of the general public
(Freiburg/Germany). The present analysis focused on
low-risk women. Therefore, women with breast cancer
(n=24) and women with a family history of breast cancer
(n=68) were excluded from the analyses. Thus, the find-
ings reported here are based on a total sample of 377
women. The mean age of the women was 43.4 years
(SD=11.90), ranging from 21 to 65. Fifty-eight percent
of the women were married, 28% were single, 12% were
divorced, and a few women were widowed (2%). Forty-
eightpercentofthewomenhaddoneanapprenticeship,
34% had completed university, 10% had none and 6%
had another vocational education. About 2% of the wo-
men did not answer this question. In regard to employ-
mentstatus,twothirdofthewomenwerefullorpart-time
employed (66%) and about 27% of the women were
trainees, pensioners or homemakers. Only a small per-
centage was unemployed (3%). In comparison to the
German female population much more women of the
study sample completed university (6% vs. 34%), but
there were no differences in age and occupation.
Measures
Interest in genetic testing for breast cancer risk
We measured women's interest in genetic testing for
breast cancer risk with four items concerning their inten-
tions to 1. discuss the issue with family or friends (vari-
able label: 1. discussion), 2. ask a medical practitioner
for informationaboutthis issue(2. information),3. make
use of genetic counseling (3. counseling), and 4. pursue
genetic testing (4. testing). Women were asked to judge
their intention on a 4-point scale from 0=definitely not to
3=definitely yes.
Intrusions
We assessed breast cancer worries with a modified Ger-
man version of the intrusion sub-scale of the Impact of
Event Scale [45], [46]. Seven items asked women how
their risk of breast cancer had affected them during the
past seven days (5. ies1 to 11. ies7), for example "I
thought about my breast cancer risk when I didn't mean
to." (5. ies1). Responses were scored on a 4-point scale
from 0=not at all to 3=often.
Perceived severity for breast cancer
Perceived severity for breast cancer was measured by
two items. Items asked each participant how serious it
wouldbeif1."…shewerefoundtocarryanalteredbreast
cancer gene" (12. mutation) and if 2."…she would get
breast cancer someday" (13. breast cancer). We scored
items on a 5-point scale from 0=somewhat serious to
4=extremely serious.
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Women were asked to estimate both their chance of
having an altered breast cancer gene (14. mutation) and
theirchanceofgettingbreastcancersomeday(15.breast
cancer). We used a 7-point scale with verbal response
categories (0=no risk to 6=absolutely certain).
Knowledge about breast cancer genetics
We assessed knowledge about breast cancer genetics
byaskingfourtrueorfalsequestionsaccordingtoLerman
et al. (1997) [29]: 1. "A father can pass down an altered
BRCA1 gene to his children." (16. father), 2. "A woman
who does not have an altered BRCA1 gene can still get
breast cancer." (17. without mutation), 3. "A woman who
has an altered BRCA1 gene has a higher breast cancer
risk."(18. higherrisk),4. "Allwomenwhohaveanaltered
BRCA1 gene get breast cancer." (19. all women).
Expectations concerning predictive genetic testing for
breast cancer risk
To measure women's expectations concerning genetic
testingforbreastcancerriskwegeneratedalistofseven
possible reasons in favor of the test (presented as
statements): 1. to learn something about the risk of the
children(20.riskofchildren),2.togetrecommendations
concerning screening behavior (21. screening), 3. to use
theresultforfutureplanning(22.future),4.togetrecom-
mendations about treatment options (23. treatment), 5.
to get certainty about personal breast cancer risk (24.
certainty), 6. to use the result for family planning (25.
family planning), and 7. to reduce breast cancer worries
(26. reduce worry). We asked women to judge on a 4-
point scale (0=not relevant to 3=extremely relevant) how
much the presented topics would be relevant for them if
they had to decide whether to undergo testing or not.
Fears concerning predictive genetic testing for breast
cancer risk
Women's fears concerning genetic testing for breast
cancer risk were assessed with six statements which
presented the following reasons against genetic testing:
1. the result could be a burden for the family (27. bur-
dens), 2. cancer cannot be prevented (28. prevention),
3.theresultcouldhavenegativeconsequencesforhealth
insurance(29. insurance),4. theresultcouldbe inaccur-
ate (30. inaccurate result), 5. a positive test result could
increasebreastcancerworries(31.increasedworry),and
6. waiting for the result could be a strain (32. waiting for
result). The items were scored on a 4-point scale (0=not
relevant, 3=extremely relevant).
Attitudes concerning genetics and genetic testing
To assess women's general attitudes toward genetics
and genetic testing participants were asked to judge the
following four items (according to Human Genetics Com-
mission [4]) on a 5-point scale from 1=strongly disagree
to4=stronglyagree:1."Coupleswhoareatriskofhaving
a child with a serious genetic disorder should be discour-
agedfromhavingchildrenoftheirown."(33.nochildren),
2. "People should be encouraged to be tested in young
adulthood for disorders that develop in middle age or
later in life." (34. testing adults), 3. "Parents have a right
to ask for their child to be tested for genetic disorders
that develop in adulthood." (35. testing children), and 4.
"New genetic developments will mean children who are
healthierandfreefrominheriteddisabilities."(36.healthy
children).
Statistical analyses
We used Structural Equation Modeling (SEM) to identify
factors that predict interest in genetic testing for breast
cancer risk of women in the general public. SEM offers
the advantages to assess complex interrelated, depend-
ent relationships at the same time as well as to take
measurementerrors into account.The model was gener-
ated, modified and validated in a five-step approach. In
a first step the study sample of N=377 women was ran-
domly divided in half, resulting in sample 1 (n=181) and
sample2(n=196).Inordertoverifywhethertherandom-
ized split was successful we performed chi-square tests
as well as independent t-tests of demographic variables
andallvariablesintendedtobeinthemodel.Inasecond
stepaninitialmodelwasdevelopedbasedontheoryand
experientialvariablesthatwerefoundsignificantinprevi-
ous research (Figure 1). The following variables were
defined as latent variables: interest in genetic testing for
breast cancer risk (main outcome variable), intrusions,
perceived severity for breast cancer, perceived vulnerab-
ility for breast cancer, knowledge about breast cancer
genetics, expectations, fears and attitudes concerning
genetictesting.Wehypothesizedthateachlatentvariable
has a direct impact on women's interest in testing. We
further assumed that women's general attitude toward
geneticsandgenetictestinginfluencesexpectationsand
fears concerning genetic testing for breast cancer risk
directly. Moreover, we expected that women's perceived
severity for breast cancer has a direct impact on per-
ceived vulnerability for breast cancer and on intrusion
and is further correlated with women's knowledge about
breast cancer. In addition, we presumed that women's
perceived vulnerability for breast cancer is influenced by
perceived severity, intrusion and knowledge.
All latent variables were measured by at least two mani-
fest variables. Before SEM analyses of the covariance
matrixwereconducted,wecheckedwhetherthepostula-
tion of normal distribution of the manifest variables was
fulfilled. P-P-plot analyses and K-S-tests of normal distri-
bution indicated that none of the manifest variables ful-
filled the postulation of normal distribution. Therefore,
exponential transformations were conducted in order to
obtain or approximate a normal distribution. After that,
thegoodnessoffitofthehypothesizedmodelwastested
by using sample 1. In the third step we modified the
model according to modification indices. After every
modification we tested the goodness of fit indices to de-
termine whether the modifications improved model fit,
again using sample 1. In the fourth step this restricted
model was validated by using sample 2. Finally, the
modified and validated structural equation model was
applied to the total sample (N=377) and the overall
goodness of fit was assessed.
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All SEM analyses were performed with AMOS 5.0 [47].
Forallanalysesmaximumlikelihoodestimateswereused
and the Full Information Maximum Likelihood algorithm
was used to account for missing data. Overall goodness
of fit was assessed with χ
2/ degree of freedom ratio
(CMIN/DF), the normed fit index (NFI), the comparative
fit index (CFI), the goodness of fit (GFI), the adjusted
goodness of fit index (AGFI), the root mean square error
of approximation (RMSEA), and the PCLOSE-value. For
CMIN/DF a ratio of less than 1.5 is considered to be very
good,aratiooflessthantwoisgood[48].ARMSEA-value
of about .05 or less indicates a close fit of the model in
relation to the degrees of freedom [49], [50] and the
PCLOSE-valueisa"pvalue"fortestingthenullhypothesis
that the population RMSEA is no greater than .05. For all
other fit indices (NFI, CFI, GFI, AGFI) values close to 1.00
are indicators of good fit [48], [51], [52].
Results
Descriptive statistics
Descriptive statistics of the total sample concerning the
variables in the model are shown in Table 1. Concerning
interest in testing as the main outcome variable it is no-
ticeablethatwomenweremoreinterestedininformation
and discussion about genetic testing for breast cancer
risk than in the uptake of counseling or testing.
There were no significant differences in demographic
variables between sample 1 and sample 2. However, we
found significant differences in expectations and fears
concerninggenetic testingfor breastcancerrisk: women
insample2ratedtheexpectationtogetinformationabout
theirchildren'sriskmorerelevantthanwomeninsample
1(t(375)=2.03;p=.043).Furthermore,womeninsample
1ratedthefearsthatapositivetestresultcouldincrease
breastcancerworriesandthatwaitingfortheresultcould
beastrainsignificantlymorerelevantfordecisionmaking
than women in sample 2 (t(369)=2.28; p=.023 respect-
ively t(366)=2.14; p=.033). In order to judge whether
these differences are relevant for interpreting the final
results we calculated effect sizes. For all of the three
variables we found small effects ranging from d=.21 to
d=.23.Thus,wecanassumethatthedifferencesbetween
sample 1 and sample 2 concerning the mentioned vari-
ables are not relevant for the following results.
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Structural equation modeling
The initial test of the hypothesized structural equation
model resulted in a moderate model fit (CMIN=925,651;
DF=580; CMIN/DF=1.596; NFI=.599; CFI=.790;
GFI=.599; AGFI=.311; RMSEA=.058; PCLOSE=.039).
According to modification indices we excluded the mani-
fest variables "8. ies4", "29. insurance" and "33. no chil-
dren". Furthermore, we added correlations between per-
ceived severity and expectations (due to methodological
constraints the correlation with the error term e41 was
used),betweenperceivedseverityandfears(respectively
the error term e40), and between perceived severity and
attitudes concerning genetic testing. Additionally, local
dependencies between the error terms e1 and e2,
between e15 and e18, between e20 and e21, between
e22ande23,andbetweene26ande29wereset.These
alterations resulted in a better model fit (Figure 2). The
goodnessoffitindiceswereacceptable(CMIN/DF=1.298;
NFI=.708; CFI=.909; GFI=.708.; AGFI=.654; RM-
SEA=.041;PCLOSE=.958)andasolutionwasadmissible.
Therefore, the model was accepted. For factor loadings
of the latent variables see Table 1.
In the next step, the modified model was validated using
sample2.Again,wefoundaplausiblemodelwithaccept-
able goodness of fit indices (CMIN=638.354; DF=473;
CMIN/DF=1.350; NFI=.716; CFI=.902; GFI=.666; AG-
FI=.613;RMSEA=.042;PCLOSE=.938).Themodifiedand
validated model was used to test the total sample. This
again resulted in a plausible model with an acceptable
model fit (CMIN=755.634; DF=473; CMIN/DF=1.598;
NFI=.799;CFI=.912;GFI=.799;AGFI=.763;RMSEA=.040;
PCLOSE=.999). Figure 3 presents the final model. As
shown in Table 1 all factor loadings were satisfactory ex-
cept for the manifest variables "1. discussion", "16. fa-
ther","27.burdens","28.prevention",and"30.inaccurate
result". Forty-two percent of the variance of interest in
genetictestingforbreastcancerriskwasexplained.Most
predictive value had expectations concerning genetic
testing for breast cancer risk (β=.41) which were again
stronglyinfluencedbyattitudesconcerninggenetictesting
(β=.47).Thetwopsychologicalvariablesperceivedvulner-
ability (β=.21) and intrusions (β=.17) as well as the two
attitudinal variables attitudes concerning genetic testing
(β=.21) and fears concerning genetic testing for breast
cancer risk (β=-.13) were of lower but also of substantial
predictivevalue.Similartowomen'sexpectationsconcern-
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ing genetic testing for breast cancer risk also fears con-
cerning the gene test were influenced by the factor atti-
tudes concerning genetic testing (β=-.13). Perceived
severity for breast cancer (β=-.06) and knowledge about
breastcancergenetics(β=-.05)didnotinfluenceinterest
in genetic testing. However, perceived severity was
moderately correlated with expectations (r=.20), fears
(r=.39) and attitudes concerning genetic testing (r=.32).
Furthermore,perceivedseveritystronglyinfluencedintru-
sions(β=.42)whichinturnpredicted10%ofthevariance
of perceived vulnerability (β=.33).
Discussion
The present study aimed at finding factors that predict
interest in genetic testing for breast cancer risk of low-
risk women of the general public in Germany. We were
able to get information about factors that influence in-
terest in genetic testing for breast cancer risk of low-risk
women and to show relationships between relevant vari-
ables.Atotalof42%ofthevarianceofinterestingenetic
testing for breast cancer risk was explained by attitudes
concerning genetic testing on the one hand and breast
cancer cognitions on the other hand.
Inregardtowomen'sattitudesconcerninggenetictesting
for breast cancer risk in particular as well as toward ge-
netic testing in general our data support the assumption
of models of health behavior that attitudes are key vari-
ables for predicting health behavior [43], [44], [53]. We
found that women's expectations concerning genetic
testing for breast cancer risk - which we considered as
an expression of their attitude concerning the test - are
strongly predicting women's interest in testing. Women
who anticipate more positive consequences of the gene
test are more interested in genetic testing for breast
cancer risk. In contrast, fears concerning the test, which
are negatively influencing women's interest, seem to be
of lower predictive value.
Regarding women's attitudes concerning genetic testing
in general we found that these attitudes are of direct as
well as of indirect predictive value for interest in genetic
testing for breast cancer risk. Women with positive atti-
tudes toward genetic testing in general are more inter-
estedingenetictestingforbreastcancerrisk.Anindirect
influence of women's general attitudes might be repres-
ented by its strong influence on specific expectations
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assume that the strong impact of women's specific ex-
pectations on interest in testing may partially be due to
women'sgeneralattitudesconcerningthesetechniques.
In contrast, the influence of women's general attitudes
on fears concerning the test is much lower. Thus, the
specific attitude concerning genetic testing for breast
cancer risk and - in consequence - women's interest in
thetestseemtobemoreinfluencedby positiveattitudes
toward genetic testing in general than by a negative view
ofthesetechniques.Inaddition,thecorrelationsbetween
perceived severity for breast cancer and the attitudinal
variables suggest that attitudes concerning such tech-
niques are not independent from the perceived personal
threat by such a disease.
Besides women's attitudes concerning genetic testing,
also breast cancer cognitions predict interest in genetic
testing for breast cancer risk. We found that women who
feel more vulnerable for breast cancer and who have
moreintrusionsaboutbreastcanceraremoreinterested
in testing. This is consistent with findings from a study
which applied the Protection Motivation Theory to invest-
igate predictors of women's motivation to obtain the test
[26].Furtheron,accordingtopreviousfindingsaboutthe
relationship between cancer worries and breast cancer
riskperception[31], [32], [33], wefoundastrongassoci-
ation between intrusions and perceived vulnerability for
breast cancer. Breast cancer intrusions seem to trigger
women's perceived vulnerability for breast cancer and
might therefore not only be of direct but also of indirect
predictive value for interest in genetic testing. However,
we have to take into account that the strong association
betweenintrusionsandperceivedvulnerabilityforbreast
cancer might be influenced by women's perceived
severity for breast cancer because of its strong impact
on intrusions.
Contrary to our expectations, we found no influence of
perceivedseverityoninterestingenetictestingforbreast
cancer risk. However, our data suggest that perceived
severity might be a variable which affects interest in ge-
netic testing for breast cancer risk by its relation to other
relevant factors. The strong relationship between per-
ceived severity and intrusion indicates that perceived
severity rather influences interest in genetic testing via
breast cancer intrusions than in a direct way. Further-
more, the association between perceived severity and
women's expectations, fears and general attitudes con-
cerning genetic testing might be a sign for an indirect
impact of perceived severity on interest in testing.
Although perceived severity and perceived vulnerability
for breast cancer are discussed as strongly related vari-
ables[19],[20],[21],[54],wefoundnorelationbetween
perceived severity and perceived vulnerability for breast
cancer. But, breast cancer intrusions might have a mod-
eratingeffectbecauseperceivedseverityseemstotrigger
intrusions which in turn increase women's perceived
vulnerability for breast cancer. Thus, perceived severity
and perceived vulnerability might be indirectly related to
each other.
Knowledge demonstrated no relationship to interest in
genetic testing for breast cancer risk. According to previ-
ous findings we expected that women who know more
aboutbreastcancergeneticsarelessinterestedingenet-
ic testing for breast cancer risk [34], [55]. To be aware
that the personal genetic background does not refer to
an increased breast cancer risk might help women to
realize that genetic testing for breast cancer risk will not
give them the certainty they may hope for. However, our
findings suggest that increasing women's knowledge
might not decreasewomen'sinterestin testing.This may
on the one hand be due to the assessmentof knowledge
because we only included questions which were related
to breast cancer genetics but not to the gene test in par-
ticular. On the other hand, interest in genetic testing in-
cluded not only the intention to make use of genetic
counseling and to pursue genetic testing but also to dis-
cuss the issue in the family or to search for more inform-
ation. Both latter intentions don't have to be a sign for
havingunrealisticexpectationsandinadequateintentions
concerninggenetictestingforbreastcancerrisk.Despite
having a realistic perception of the personal risk status
duetoknowledgeaboutbreastcancerandbreastcancer
genetics, women may intend to deal with the issue by
searching for information or discussing it with related
persons. Furthermore, participating in our study might
have motivated women to engage themselves in the is-
sue.
The study has some limitations that should be noted.
First, the outcome of this study was interest in genetic
testing for breast cancer risk. It was measured by the in-
tention to discuss the issue with family and friends, by
theintentiontosearchformoreinformation,bytheinten-
tion to make use of genetic counseling as well as to pur-
suethegenetests.Thesefourintentionsrepresentdiffer-
entlevelsofinterest.Thus,ithastobetakenintoaccount
that interest in genetic testing as it was defined in our
study is a global construct. Furthermore, other data indi-
cate that interest in and actual uptake of genetic testing
mightbedifferent[56].Secondly,thedataandtheresult-
ing structural equation model are from a cross-sectional
sample. Therefore, path models do not demonstrate
causation. Third, there may be a selection bias in the
sample which limits generalizability. The women of our
sample were higher educated than German women of
the general public which may indicate that women's in-
terest in genetic testing for breast cancer risk might also
be influences by the educational level. Higher educated
womenmightdealwiththesenewtechnologiesinamore
sophisticatedway thanlowereducatedwomen.Thus,we
shouldtakeintoaccountthattheinfluencesoftheinvest-
igated factors on interest in genetic testing for breast
cancerriskmight be differentin a lesseducated sample.
Conclusions
Low-risk women with more expectations concerning the
test, a positive attitude concerning genetic testing in
9/11 Psycho-Social-Medicine 2004, Vol. 1, ISSN 1614-2934
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and more breast cancer intrusions are more interested
in genetic testing for breast cancer risk. Except for the
generalattitudeconcerninggenetictesting,thesefindings
are similar to the results of studies on women with a
family history of breast cancer or breast cancer them-
selves. Thus, also women at low to moderate breast
cancer risk should receive information about breast
cancergeneticsandthe genetestthatfocuson decreas-
ingexaggeratedbreastcancerriskperceptionsandbreast
cancer intrusions. In addition, counseling of low-risk wo-
men should focus on underlying attitudes and expecta-
tionsconcerninggenetictestinginordertoreduceunreal-
isticbeliefsandhopesaswellastoinfluenceinadequate
health behavior. Women might interpret the test rather
as a possibility of health prevention than as a diagnostic
instrument. They might therefore need more detailed in-
formation about the gene test, its chances and limits.
This might help them to verify and revise their expecta-
tions. Thereby women's interest in genetic testing for
breast cancer risk might decrease.
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